Dalynah Maldonado1, Emilee Tu2, Shereen Mahmood1, Dawn Wahezi2,3, Ruchika Darapaneni2, Niloofar Sima2, Laura Curiel-Duran3, Lindsay M Pattison2, Vilma Gabbay4,5, Laurie J Bauman4,6, Anna Broder1, Tamar B Rubinstein2,3. 1. Albert Einstein College of Medicine, Department of Medicine, Division of Rheumatology, Bronx, New York, USA. 2. Albert Einstein College of Medicine, Department of Pediatrics, Division of Pediatric Rheumatology, Bronx, New York, USA. 3. Children's Hospital at Montefiore, Division of Pediatric Rheumatology, Bronx, New York, USA. 4. Albert Einstein College of Medicine, Department of Psychiatry and Behavioral Sciences, Bronx, New York, USA. 5. Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, USA. 6. Albert Einstein College of Medicine, Department of Pediatrics, Bronx, New York, USA.
Abstract
OBJECTIVE: Due to concerns of infection and medication disruptions during the COVID-19 pandemic, rheumatology patients at the pandemic epicenter were at risk of distress and poor health outcomes. We sought to investigate medication disruptions and COVID-related distress shortly after the peak of the pandemic in the Bronx, NY, and determine whether factors related to the pandemic were associated with flares, disease activity, and overall health. METHODS: We surveyed adult patients and parents of pediatric patients from rheumatology clinics in the Bronx, in the month following the epidemic peak regarding medication access, medication interruptions, COVID-19 infection, COVID-19 hospitalization, and COVID-related distress. We examined which factors associated with patient-reported flares, disease activity, and overall health scores in regression models accounting for socio-demographics and rheumatologic disease type. RESULTS: Of 1,692 patients and parents contacted, 361 (21%) responded; 16% reported medication access difficulty, 14% medication interruptions, and 41% flare. In a multivariable logistic regression model, medication access difficulty was associated with increased odds of flare (OR 4.0, 95% CI 1.5-10.4, p=0.005), as was high COVID-related distress (OR 2.4, 95% CI 1.2-4.6, p=0.01). In multivariable linear regression models, medication access difficulty and high distress were associated with worse disease activity scores and high distress was associated with worse health scores. CONCLUSION: Medication access difficulties and flares were common among rheumatology patients from the Bronx, NY in the month following the epidemic peak. Medication access difficulty and COVID-related distress were highly associated with flare and disease activity. COVID-related distress was associated with overall health scores. This article is protected by copyright. All rights reserved.
OBJECTIVE: Due to concerns of infection and medication disruptions during the COVID-19 pandemic, rheumatology patients at the pandemic epicenter were at risk of distress and poor health outcomes. We sought to investigate medication disruptions and COVID-related distress shortly after the peak of the pandemic in the Bronx, NY, and determine whether factors related to the pandemic were associated with flares, disease activity, and overall health. METHODS: We surveyed adult patients and parents of pediatric patients from rheumatology clinics in the Bronx, in the month following the epidemic peak regarding medication access, medication interruptions, COVID-19infection, COVID-19 hospitalization, and COVID-related distress. We examined which factors associated with patient-reported flares, disease activity, and overall health scores in regression models accounting for socio-demographics and rheumatologic disease type. RESULTS: Of 1,692 patients and parents contacted, 361 (21%) responded; 16% reported medication access difficulty, 14% medication interruptions, and 41% flare. In a multivariable logistic regression model, medication access difficulty was associated with increased odds of flare (OR 4.0, 95% CI 1.5-10.4, p=0.005), as was high COVID-related distress (OR 2.4, 95% CI 1.2-4.6, p=0.01). In multivariable linear regression models, medication access difficulty and high distress were associated with worse disease activity scores and high distress was associated with worse health scores. CONCLUSION: Medication access difficulties and flares were common among rheumatology patients from the Bronx, NY in the month following the epidemic peak. Medication access difficulty and COVID-related distress were highly associated with flare and disease activity. COVID-related distress was associated with overall health scores. This article is protected by copyright. All rights reserved.
Authors: Jenny Leese; Catherine L Backman; Jasmin K Ma; Cheryl Koehn; Alison M Hoens; Kelly English; Eileen Davidson; Shanon McQuitty; James Gavin; Jo Adams; Stephanie Therrien; Linda C Li Journal: Health Expect Date: 2021-08-17 Impact factor: 3.318
Authors: Roberta Naddei; Renata Alfani; Martina Bove; Valentina Discepolo; Filomena Mozzillo; Alfredo Guarino; Maria Alessio Journal: Arthritis Care Res (Hoboken) Date: 2021-08-16 Impact factor: 5.178
Authors: Sarah Ryan; Paul Campbell; Zoe Paskins; Samantha Hider; Fay Manning; Katrina Rule; Michael Brooks; Andrew Hassell Journal: BMJ Open Date: 2022-07-26 Impact factor: 3.006
Authors: Jane Maddock; Sam Parsons; Giorgio Di Gessa; Michael J Green; Ellen J Thompson; Anna J Stevenson; Alex Sf Kwong; Eoin McElroy; Gillian Santorelli; Richard J Silverwood; Gabriella Captur; Nishi Chaturvedi; Claire J Steves; Andrew Steptoe; Praveetha Patalay; George B Ploubidis; Srinivasa Vittal Katikireddi Journal: BMJ Open Date: 2022-10-13 Impact factor: 3.006
Authors: Nevena Rebić; Jamie Y Park; Ria Garg; Ursula Ellis; Ayano Kelly; Eileen Davidson; Mary A De Vera Journal: Arthritis Care Res (Hoboken) Date: 2021-07-05 Impact factor: 5.178